Results 11 to 20 of about 309,185 (347)
Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.
New England Journal of Medicine, 2022 BACKGROUND Neonatal hypoxic-ischemic encephalopathy is an important cause of death as well as long-term disability in survivors. Erythropoietin has been hypothesized to have neuroprotective effects in infants with hypoxic-ischemic encephalopathy, but its
Yvonne W Wu +37 more
semanticscholar +1 more source
COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features
Radiology, 2020 Since its introduction to the human population in December 2019, the coronavirus disease 2019 (COVID-19) pandemic has spread across the world with over 330,000 reported cases in 190 countries (1). While patients typically present with fever, shortness of
Neo Poyiadji +5 more
semanticscholar +1 more source
Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy
Cureus, 2020 Coronavirus disease 2019 (COVID-19) is a pandemic. Neurological complications of COVID-19 have not been reported. Encephalopathy has not been described as a presenting symptom or complication of COVID-19.
A. Filatov +3 more
semanticscholar +1 more source
Frontiers in Pharmacology, 2023 Background: Herbal medicine can provide adjunctive therapy for adults with post-stroke depression. This study summarizes the latest evidence regarding the harms and benefits of herbal antidepressants.Methods: The literature searched from the Cochrane ...
Jian Zhang +11 more
doaj +1 more source
Frontiers in Cell and Developmental Biology, 2020 Depression is a major cause of disease burden and severely impairs well-being of patients around the globe. Geniposide (GP) has been revealed to play a significant role in depression treatment.
Tianyu Zou +9 more
doaj +1 more source
Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients
Annals of Clinical and Translational Neurology, 2020 Covid‐19 can involve multiple organs including the nervous system. We sought to characterize the neurologic manifestations, their risk factors, and associated outcomes in hospitalized patients with Covid‐19.
Eric M. Liotta +6 more
semanticscholar +1 more source
Frontiers in Pharmacology, 2021 Background: To update the efficacy and safety data of monoclonal antibodies for the treatment of neuromyelitis optica spectrum disorders (NMOSD) and explore the differences in the effect of treatment between patients seropositive and seronegative for ...
Fanxin Kong +11 more
doaj +1 more source
Hashimoto’s Encephalopathy [PDF]
Clinical and Experimental Neuroimmunology, 2016 AbstractHashimoto encephalopathy (HE) is an autoimmune encephalopathy associated with autoimmune chronic thyroiditis. The clinical entity and nosology of HE have long been debated. Recently, new autoantibodies associated with autoimmune encephalitis have been discovered.
Akiko Matsunaga +2 more
openaire +2 more sources
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2022 AbstractInherited neurotransmitter diseases are a subset of rare neurometabolic disorders characterized by hereditary deficiencies in neurotransmitter metabolism or transport. Non-ketotic hyperglycinaemia (NKH), called glycine encephalopathy, is an autosomal recessive glycine metabolism disorder characterized by an abnormal accumulation of glycine in ...
S. Bhumika +3 more
openaire +3 more sources
Wernicke’s Encephalopathy [PDF]
Cureus, 2018 Wernicke's encephalopathy (WE) is a neurologic emergency that requires immediate attention to prevent permanent neurological morbidity and mortality. It presents with confusion, ophthalmoplegia and gait ataxia which together comprise its classic triad.
Smit Patel +2 more
openaire +3 more sources